港股创新药ETF低开高走涨超1.5%,晶泰控股涨超9%,机构:看好具备全球竞争优势的创新药及相关产业链

21世纪经济报道
11 Apr

4月11日,恒生指数、恒生科技指数低开,国证港股通创新药指数低开高走。相关ETF方面,港股创新药ETF(159567)低开后持续拉升翻红,截至发稿,该ETF涨1.54%。成分股方面,晶泰控股涨超9%,君实生物、石药集团、联邦制药、康希诺生物等股涨幅居前。资金面上,金融终端最新数据显示,港股创新药ETF(159567)昨日获资金净流入超9000万元,近5个交易日累计“吸金”超2.9亿元。...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10